Kashyap Tele-Medicines Ratios

Kashyap Tele-Medicines Ltd Ratios

The Kashyap Tele-Medicines Ltd Ratios page provides a complete fundamental analysis of Kashyap Tele-Medicines Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Kashyap Tele-Medicines Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Kashyap Tele-Medicines Ltd (NSE: , BSE: 531960) is currently trading at ₹4.57, with a market capitalization of ₹241.47M. As a major player in the Technology services sector and Packaged software industry, Kashyap Tele-Medicines Ltd remains a key stock for fundamental analysis using Kashyap Tele-Medicines Ltd Ratios.

Kashyap Tele-Medicines Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Kashyap Tele-Medicines Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Kashyap Tele-Medicines Ltd Ratios.

Historically, the Kashyap Tele-Medicines Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 3480
• 2021: 0
• 2020: 295.65

The decline in Kashyap Tele-Medicines Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Kashyap Tele-Medicines Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 34.77.

Historical P/B trend:

• 2024: 34.77
• 2023: 15.51
• 2022: 14.89
• 2021: 4.87

Kashyap Tele-Medicines Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Kashyap Tele-Medicines Ltd P/S ratio currently stands at 115.83, an important part of Kashyap Tele-Medicines Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 115.83
• 2023: 51.70
• 2022: 50.76
• 2021: 16.60

The rising Kashyap Tele-Medicines Ltd P/S ratio indicates improved revenue valuation by investors.

Kashyap Tele-Medicines Ltd Price to Cash Flow Ratio (P/CF)

The Kashyap Tele-Medicines Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Kashyap Tele-Medicines Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 138.72
• 2021: 0
• 2020: 121.13

The declining Kashyap Tele-Medicines Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Kashyap Tele-Medicines Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Kashyap Tele-Medicines Ltd EV currently stands at ₹222.35M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 222.35M
• 2023: 98.36M
• 2022: 98.81M
• 2021: 32.24M

Kashyap Tele-Medicines Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Kashyap Tele-Medicines Ltd EV/EBITDA ratio is currently 0, a key metric in Kashyap Tele-Medicines Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 2410
• 2021: 0

Stable Kashyap Tele-Medicines Ltd EV/EBITDA indicates balanced valuation.

Kashyap Tele-Medicines Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Kashyap Tele-Medicines Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Kashyap Tele-Medicines Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Kashyap Tele-Medicines Ltd ROE currently stands at -0.05%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -0.05
• 2023: -4.58
• 2022: 0.46
• 2021: -112.89

Declining ROE indicates pressure on profitability.

Kashyap Tele-Medicines Ltd Ratios Analysis Summary

The Kashyap Tele-Medicines Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Kashyap Tele-Medicines Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Kashyap Tele-Medicines Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.